Abstract
The pharmacokinetic characterization of coumarin drugs may be used as an example of how one may analyze the time course of an indirect effect, having no apparent relationship to the drug concentrations in the plasma, such as is seen for the lowering of prothrombin complex activity. Resolution of the data into measures of the “direct” effect (i.e., inhibition of synthesis of clotting factor activity) permits excellent correlation between effect and drug concentration. The parallel development of a suitable animal model (the rat) has provided the opportunity to study the pharmacokinetics of the anticoagulant effect of the coumarin drugs and of their interaction with other drugs not only in the plasma but also at the tissue level. Selected results of an examination of the kinetics of drug distribution and elimination as well as the kinetics of drug action in both man and animals are presented here for the coumarin drugs as an example of a comprehensive pharmacokinetic investigation.
Similar content being viewed by others
References
R. A. O'Reilly and P. M. Aggeler. Determinants of the response to oral anticoagulant drugs in man.Pharmacol. Rev. 22: 35–96 (1970).
R. A. O'Reilly, E. Nelson, and G. Levy. Physicochemical and physiologic factors affecting the absorption of warfarin in man.J. Pharm. Sci. 55: 435–437 (1966).
R. A. O'Reilly, P. M. Aggeler, and L. S. Leong. Studies on the coumarin anticoagulant drugs: Comparison of the pharmacodynamics of dicumarol and warfarin in man.Thromb. Diath. Haemorrh. 11: 1–22 (1964).
G. Levy. Dose dependent effects in pharmacokinetics. InImportance of Fundamental Principles in Drug Evaluation (D. H. Tedeschi and R. E. Tedeschi, eds.), Raven Press, New York, 1968, pp. 141–172.
G. Levy, T. Tsuchiya, and L. P. Amsel. Limited capacity for salicylic acid conjugation with glycine in man.Clin. Pharmacol. Therap. 13: 258–268 (1972).
T. Tsuchiya and G. Levy. Relationship between dose and plateau levels of drugs eliminated.J. Pharm. Sci. 61: 541–544 (1972).
G. Levy. Kinetics of pharmacologic effects.Clin. Pharmacol. Therap. 7: 362–372 (1966).
G. Levy. Correlation between drug concentration and drug response in man: Pharmacokinetic considerations.Proc. Fifth Internat. Congr. Pharmacol. 3: 34–55 (1973).
R. Nagashima, G. Levy, and E. Nelson. Comparative pharmacokinetics of coumarin anticoagulants. I. Unusual interaction of bishydroxycoumarin with plasma proteins-development of a new assay.J. Pharm. Sci. 57: 58–67 (1968).
G. Levy and R. Nagashima. Comparative pharmacokinetics of coumarin anticoagulants. VI. Effect of plasma protein binding on the distribution and elimination of bishydroxycoumarin by rats.J. Pharm. Sci. 58: 1001–1004 (1969).
G. Levy, J. J. Ashley, E. Jahnchen, and D. Perrier. Hydroxylated metabolites as inhibitors of drug biotransformation and their possible roles in dose dependent elimination kinetics.Abst. 13th Natl. Mtg. APhA Acad. Pharm. Sci. 2: 179–180 (1972).
R. Nagashima, R. A. O'Reilly, and G. Levy. Kinetics of pharmacologic effects in man: The anticoagulant action of warfarin.Clin. Pharmacol. Therap. 10: 22–35 (1969).
G. Levy, R. A. O'Reilly, P. M. Aggeler, and G. M. Keech. Pharmacokinetic analysis of the effect of barbiturate on the anticoagulant action of warfarin in man.Clin. Pharmacol. Therap. 11:372–377 (1970).
J. N. Eble, B. D. West, and K. P. Link. A comparison of the isomers of warfarin.Biochem. Pharmacol. 15: 1003–1006 (1966).
A. Breckenridge and M. Orme. The plasma half lives and the pharmacological effect of the enantiomers of warfarin in rats.Life Sci. 11: 337–345 (1972).
D. S. Hewick. Plasma half lives of enantiomers of warfarin in warfarin-resistant and warfarin-susceptible rats.J. Pharm. Pharmacol. 24: 661–662 (1972).
R. A. O'Reilly and G. Levy. Kinetics of the anticoagulant effect of bishydroxycoumarin in man.Clin. Pharmacol. Therap. 11: 378–384 (1970).
L. B. Wingard, Jr., and G. Levy. Kinetics of anticoagulant effect of dicumarol in rats.J. Pharmacol. Exptl. Therap. 184: 253–260 (1973).
R. Nagashima, G. Levy, and E. J. Sarcione. Comparative pharmacokinetics of coumarin anticoagulants. III. Factors affecting the distribution and elimination of bishydroxy-coumarin (BHC) in isolated liver perfusion studies.J. Pharm. Sci. 57: 1881–1888 (1968).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Levy, G. Comparative pharmacokinetics of the anticoagulant effect of coumarin drugs in man and rat. Journal of Pharmacokinetics and Biopharmaceutics 1, 541–551 (1973). https://doi.org/10.1007/BF01059790
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01059790